Chronic obstructive pulmonary disease (COPD) assessment test scores corresponding to modified Medical Research Council grades among COPD patients

Korean Journal of Internal Medicine

Volumn 30, Issue 5, 2015, Pages 629-637

  Lee, Chang Hoon ^a   Lee, Jinwoo ^a   Park, Young Sik ^a   Lee, Sang Min ^a   Yim, Jae Joon ^a   Kim, Young Whan ^a   Han, Sung Koo ^a   Yoo, Chul Gyu ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

Chronic obstructive; Classification; COPD assessment test; Modified Medical Round Council; Pulmonary disease; Symptoms

Indexed keywords

ACCURACY; ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE ASSESSMENT TEST; DISEASE EXACERBATION; FEMALE; FOLLOW UP; HUMAN; KOREAN (PEOPLE); MAJOR CLINICAL STUDY; MALE; PREDICTION; RECEIVER OPERATING CHARACTERISTIC; RESPIRATORY TRACT DISEASE ASSESSMENT; RETROSPECTIVE STUDY; RISK ASSESSMENT; SCORING SYSTEM; SYMPTOM; ALGORITHM; CLASSIFICATION; COMPARATIVE STUDY; DECISION SUPPORT SYSTEM; DECISION TREE; EVALUATION STUDY; LUNG; MIDDLE AGED; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REGRESSION ANALYSIS; REPRODUCIBILITY; RISK FACTOR; SEVERITY OF ILLNESS INDEX; SOUTH KOREA;

AGED; ALGORITHMS; AREA UNDER CURVE; DECISION SUPPORT TECHNIQUES; DECISION TREES; FEMALE; HUMANS; LUNG; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REGRESSION ANALYSIS; REPRODUCIBILITY OF RESULTS; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; RISK FACTORS; ROC CURVE; SEVERITY OF ILLNESS INDEX;

EID: 84942114692     PISSN: 12263303     EISSN: 20056648     Source Type: Journal    
DOI: 10.3904/kjim.2015.30.5.629     Document Type: Article

References (23)

1. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (updated) [Internet]. GOLD, 2013 [cited 2015 Jul 28]. Available from: http://www.goldcopd.org/uploads/users/files/ GOLD_Report_2013_Feb20.pdf.
2. The Korean Academy of Tuberculosis and Respiratory Diseases. Guidelines for chronic obstructive pulmonary disease 2012 [Internet]. Seoul (KR): KATRD, c2007 [cited 2015 Jul 28]. Available from: http://www.lungkorea.org.
3. Zhou QT, Mei JJ, He B, et al. Chronic obstructive pulmonary disease assessment test score correlated with dyspnea score in a large sample of Chinese patients. Chin Med J (Engl) 2013;126:11-15.
4. Han MK, Muellerova H, Curran-Everett D, et al. GOLD 2011 disease severity classification in COPDGene: a prospective cohort study. Lancet Respir Med 2013;1:43-50.
5. Kirkpatrick d P, Dransfield MT. Racial and sex differences in chronic obstructive pulmonary disease susceptibility, diagnosis, and treatment. Curr Opin Pulm Med 2009;15:100-104.
6. Dransfield MT, Bailey WC. COPD: racial disparities in susceptibility, treatment, and outcomes. Clin Chest Med 2006;27:463-471.
7. Barnes PJ. Genetics and pulmonary medicine. 9. Molecular genetics of chronic obstructive pulmonary disease. Thorax 1999;54:245-252.
8. Hegab AE, Sakamoto T, Uchida Y, et al. CLCA1 gene polymorphisms in chronic obstructive pulmonary disease. J Med Genet 2004;41:e27.
9. Ho LI, Harn HJ, Chen CJ, Tsai NM. Polymorphism of the beta(2)-adrenoceptor in COPD in Chinese subjects. Chest 2001;120:1493-1499.
10. Celli BR, Thomas NE, Anderson JA, et al. Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study. Am J Respir Crit Care Med 2008;178:332-338.
11. Hansel NN, Washko GR, Foreman MG, et al. Racial differences in CT phenotypes in COPD. COPD 2013;10:20-27.
12. Kwon N, Amin M, Hui DS, et al. Validity of the COPD assessment test translated into local languages for Asian patients. Chest 2013;143:703-710.
13. Breiman L, Friedman JH, Olshen RA, Stone CJ. Classification and Regression Trees. Belmont: Wadsworth International Group, 1984.
14. Pilote L, Miller DP, Califf RM, Rao JS, Weaver WD, Topol EJ. Determinants of the use of coronary angiography and revascularization after thrombolysis for acute myocardial infarction. N Engl J Med 1996;335:1198-1205.
15. Small M, Broomfield S, Higgins V. Quantification and treatment patterns of real-world patients classified by the GOLD 2011 strategy. Thorax 2012;67:A144-A145.
16. Adamek L, Jones P, Nadeau G, Banik N. GOLD 2011: combined COPD assessment of patients from the European health-related quality of life study. Eur Respir J 2012;40(Suppl 56):1644.
17. Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004;350:1005-1012.
18. Puhan MA, Garcia-Aymerich J, Frey M, et al. Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index. Lancet 2009;374:704-711.
19. Jones PW, Tabberer M, Chen WH. Creating scenarios of the impact of COPD and their relationship to COPD Assessment Test (CAT) scores. BMC Pulm Med 2011;11:42.
20. Lemon SC, Roy J, Clark MA, Friedmann PD, Rakowski W. Classification and regression tree analysis in public health: methodological review and comparison with logistic regression. Ann Behav Med 2003;26:172-181.
21. Decramer M, Miravitlles M, Price D, et al. New horizons in early stage COPD: improving knowledge, detection and treatment. Respir Med 2011;105:1576-1587.
22. Anthonisen NR, Connett JE, Kiley JP, et al. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1: the Lung Health Study. JAMA 1994;272:1497-1505.
23. Decramer M, Celli B, Kesten S, et al. Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial. Lancet 2009;374:1171-1178.